Noninvasive, medical management for non-ST-elevation acute coronary syndromes
Mark Y Chan1, Richard C Becker, Robert A Harrington
1Duke Clinical Research Institute, Durham, NC 27705, USA. mark.chan@duke.edu
Insights
Many patients with non-ST-elevation acute coronary syndromes (NSTE ACS) are not treated invasively. These medically managed patients face higher risks and receive less guideline-recommended care, highlighting a gap in treatment strategies.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Recent guidelines emphasize invasive strategies for non-ST-elevation acute coronary syndromes (NSTE ACS).
- A significant proportion of NSTE ACS patients do not receive diagnostic angiography or revascularization.
- Medically managed NSTE ACS patients often have more comorbidities and higher-risk profiles.
Purpose of the Study:
- To analyze the characteristics and outcomes of medically managed NSTE ACS patients.
- To identify barriers to implementing contemporary medical therapies in this population.
Main Methods:
- Retrospective analysis of NSTE ACS patient data.
- Comparison of outcomes between medically managed and invasively treated patients.
- Assessment of guideline-recommended medication use.
Main Results:
- 27%-56% of NSTE ACS patients did not undergo diagnostic angiography.
- 45%-78% of NSTE ACS patients did not undergo revascularization during hospitalization.
- Medically managed patients had higher rates of comorbidities, high-risk characteristics, and adverse outcomes.
- Medically managed patients were less likely to receive guideline-recommended medications.
Conclusions:
- Medically managed NSTE ACS patients represent a vulnerable group with poorer outcomes.
- Limited evidence from clinical trials excluding these patients hinders optimal medical therapy implementation.
- Further research is needed to improve care for noninvasively managed NSTE ACS patients.
Abstract:
Despite emphasis on the use of invasive management strategies for patients with non-ST-elevation acute coronary syndromes (NSTE ACS) in recent practice guidelines, 27% to 56% of NSTE ACS patients do not undergo diagnostic angiography, and a further 45% to 78% do not undergo revascularization procedures during the initial hospitalization. These medically managed patients (also termed noninvasive management) have a greater frequency of medical comorbidities and high-risk clinical characteristics and are less likely to receive guideline-recommended medications, compared with patients who undergo revascularization procedures. The rates of short and long-term adverse outcomes are also substantially higher in medically managed NSTE ACS patients, but more widespread implementation of contemporary medical therapies in this population is limited by exclusion of medically managed patients from many randomized clinical trials.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Angina IV: Management
01:26Acute Coronary Syndrome V: Nursing Management
01:20Angina V: Nursing Management
01:30Acute Coronary Syndrome I: Introduction
01:27Coronary Artery Disease V: Interprofessional Care